As of May 22
| +0.01 / +0.56%|
The 2 analysts offering 12-month price forecasts for Infinity Pharmaceuticals Inc have a median target of 1.75, with a high estimate of 2.00 and a low estimate of 1.50. The median estimate represents a -2.23% decrease from the last price of 1.79.
The current consensus among 4 polled investment analysts is to Hold stock in Infinity Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.